Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

cancer family

Identifier: CI-CAN-00000380
Entity page: /cancer/uterine-corpus-mixed-epithelial-and-mesenchymal-neoplasm ↗
Edges: 34

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 17show all (up to 200)
→ investigated in trials for	Carboplatinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for

Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm studied in …STUDIED_INderived10 of 17show all (up to 200)
→ studied in	NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (8 active)	—	—	Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ALIAS · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 17 trials mapped (8 active)	—	—	Uterine Corpus Adenosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05156268Phase 2 · completed A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma · condition mapped ALIAS · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped ALIAS · 17 trials mapped (8 active)	—	—	Uterine Corpus Carcinosarcoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains